Or quite simply it was never recognised as a great product. If it was, it would have found a way to market much quicker, but they couldn't make it work.
255 days from now we will be closer to a cure. The Aussie trials look fantastic and that is where the money will go- those trials will get huge funding and resource as this is what is really required
Why apply for TGA approval now, they don't even need it where artimist will be applied
IMO this was a waste of time at this point
News: SUD Suda Ltd says Artimist accepted for review marketing authorisation, page-19
Add ALA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
19.0¢ |
Change
-0.015(7.32%) |
Mkt cap ! $200.9M | |||
| Open | High | Low | Value | Volume |
| 20.5¢ | 21.0¢ | 19.0¢ | $407.7K | 2.054M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 114775 | 19.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 19.5¢ | 21756 | 2 |
View Market Depth
| Last trade - 16.10pm 18/11/2024 (20 minute delay) ? |
| ALA (ASX) Chart |